Opening Ceremony

• Vicenzanephrocourses: Thirty years in three minutes - C. Ronco
• Lazaro Gotloib Memorial Lecture: Past, present and future of PD - N. Lameire

Session 1: Summit on PD around the world

• The International Society of Nephrology - G.Remuzzi
• The European Renal Association ERA-EDTA - R. Vanholder
• The EUROPD- A. Joerres
• The International Society of Peritoneal Dialysis - I. Teitelbaum
• The ISPD - Asian Chapter - K.S. Nayak
• The American Society of Nephrology - J. Burkart
• The Chinese Society of Nephrology - Z.H. Liu
• The European Society of Pediatric Nephrology - E. Verrina
• The Latin American Society of Nephrology - R. Correa-Rotter
• The Italian Society of Nephrology - G. Capasso

Session 2: Research in Peritoneal Dialysis - the last and next thirty years

• Peritoneal Membrane Morphology - G. Garosi
• Peritoneal transport - B. Rippe
• Peritoneal Membrane biology - O. Devuyst
• Peritoneal Dialysis solutions - A. Joerres
• Treatment modalities and targets - J. Burkart
• PD in pts with abdominal and thoracic abnomalities - M. Misra

Session 3: Peritoneal Dialysis Solutions

• Biocompatibility of PD solutions - R. Mehrotra
• PD solutions and nutritional status - C.Verger
• 20 years of bicarbonate solutions - M. Feriani
• Alternative dialysis strategies with icodextrin - I. Teitelbaum
• Are current solutions adequate for pediatric use? - E. Verrina

Session 4: New challenges for PD and home therapies

Session 4b: Practical Issues in Peritoneal Dialysis

• The financial benefits of home therapies - R. Greenwood
• When and how to start peritoneal dialysis - M. Schreiber
• The Brazilian PD Study (BRAZPD) - J. Divino
• Outcomes: PD vs HD - R. Mehrotra
• Hypogonadism, wasting and ESA resistance - P. Stenvinkel

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

• Getting the right patient on the right treatment - M. Perez Fontan
• Barriers and opportunities of home therapies - N. Lameire
• How to avoid technique failure in PD - J.P. Ryckelynck
• Ultrafiltration failure: diagnosis & management - W. Van Biesen

Session 5: Telemedicine and e-Health on PD

• Computer assisted Data Collection and management - C. Ronco
• Telemedicine in peritoneal dialysis - M. Rosner
• e-Health: remote health care models in PD - W. Van Biesen
• Cardiovascular complications in PD patients - D.G Struijk
• Remote monitoring of PD in special locations - K.S. Nayak

Session 6: Lipid disorders, inflammation and anemia

• Dialysis option for the very elderly - M. Rosner
• Anemia management in PD patients - F. Locatelli
• Maximising EPO response: Iron strategies - K.S. Nayak
• Lipid disorders in uremia & dialysis - G. Bakris
• Statins and lipid lowering strategies in PD - O. Heimbürger 

Session 7: CKD-MBD and Inflammation Management in PD

• Which phosphate binder in PD patients - M. Cozzolino
• Use of VDR Activitations in PD - J. Bover
  
• Calcimimetrics in PD patients - P. Messa
• Factors affecting loss of residual functions in Dialysis - N. Levin
• New therapeutic options for inflammation in PD - D. Warrock

Session 8: Fluid overload and cardiovascular

Session 8b: Practical Issues in Peritoneal Dialysis 2

• Fluid homeostasis in PD - J. Teixodo
• BIVA + BNP in PD patients - C. Crepaldi
• PD in heart failure patients - M. Schreiber
• Role of PD in Cardio-Renal patients - A. Rodrigues

 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

• PD access: what's the best approach? - M. Riella
• Catheter placement techniques - W. Van Biesen
• Infectious complications: treatment considerations - A Joerres
• Adequacy in peritoneal dialysis - J.P. Ryckelynck
• Setting up research in PD - J. Witowski

Session 9: Controversies

• Do we need PD guidelines? Yes, They are useful - N. Lameire
• Do we need PD guidelines? No, they are dangerous - R. Amerling
• Take patients off PD after 7 years to prevent EPS? Yes, we must! - F. Finkelstein
• Take patients off PD after 7 years to prevent EPS? No, there is no need - E. Brown

Session 10: Peritoneal Dialysis Technology

• Wearable technology: where are we? - C. Ronco
• Continuous Flow PD - R. Amerling
• 1 day HD and 5 days PD: does it make sense?  - J. Burkart
• Time between catheter insertion and use - I. Teitelbaum
• PD membrane evaluation in clinical practice - R. Krediet

Session 11: Peritonitis and other clinical outcomes

• Today's approaches to prevent peritonitis - B. Piraino
• Transplant outcome and dialysis modality- I. Teitelbaum
• Pancreas/Kidney transplant in PD patients - M. Schreiber
• Early diagnosis of Peritonitis: the case of NGAL - F.K. Martino
• Prognostic factors for peritonitis outcome - D.G. Struijk
• How to improve the care of diabetic patient on PD - M. Misra
• How to select among dialysis option - A. Mooney